Aurinia Pharmaceuticals Shares Rally on Report of Bristol Myers Interest
October 25 2021 - 9:25AM
Dow Jones News
By Colin Kellaher
Shares of Aurinia Pharmaceuticals Inc. rose more than 10% in
premarket trading Monday, adding on to Friday's gains, after
Bloomberg reported that Bristol Myers Squibb Co. has expressed
interest in acquiring the smaller biopharmaceutical company.
Aurinia shares, which surged nearly 27% on Friday to close at a
52-week high of $28, were recently up 10.7% to $31 in premarket
trading.
Bristol Myers recently approached the Victoria, British
Columbia, company about an acquisition, Bloomberg reported Friday,
citing people familiar with the matter.
The sources said New York-based Bristol Myers hasn't made any
final decision and could opt against any potential deal.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 25, 2021 09:10 ET (13:10 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Sep 2023 to Sep 2024